Body RevoLUTion
ActiveSummary
Body RevoLUTion has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€23,045) and a net result of -€7,966. Equity is shrinking by ~65% per year across the filed fiscal years. Its solvency ranks better than 5% of 16754 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability0=
Solvency0=
Growth32=
Track record94
Bankruptcy probability, 12 months
0.4%
Very low
0%0.5%1.5%4%10%≥ 25%
No credit on open account
Liquidity short (current ratio 0.28 against 0.37 in 2024; short-term debt: 130.5% and cash: 6.4% of total assets), and equity is negative.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
-72%
Return on assets
-24.9%
Age of the figures
9 mo
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025Equity per financial year
232425
2023 to 2025 · latest year -€23,045
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 11-07-2026, 20 days ahead of the deadline.
NBB · 3 filingsDeviation from the deadline
2025
20 d early
2024
21 d early
2023
22 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 3 accounts on average 21 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
28-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What other support did companies like this one receive, and it did not?Public money How does this company compare with its sector?Sector benchmark
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, micro schema
Equity
-€23,045▼ 52.8%
2024 · -€15,079
Total assets
€32,014▼ 18.1%
2024 · €39,082
Net result
-€7,966▲ 31.5%
2024 · -€11,634
Working capital
-€29,900▼ 15.8%
2024 · -€25,817
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line202320242025
Operating result-€6,021--€10,843▼ 80.1%-€7,225▲ 33.4%
Net result-€6,445below the sector's middle half--€11,634below the sector's middle half▼ 80.5%-€7,966below the sector's middle half▲ 31.5%
Equity-€3,445below the sector's middle half--€15,079below the sector's middle half▼ 338%-€23,045below the sector's middle half▼ 52.8%
Total assets€40,274below the sector's middle half-€39,082below the sector's middle half▼ 3.0%€32,014below the sector's middle half▼ 18.1%
Debt€43,719-€54,161▲ 23.9%€55,058▲ 1.7%
Working capital-€13,321below the sector's middle half--€25,817below the sector's middle half▼ 93.8%-€29,900below the sector's middle half▼ 15.8%
Solvency-8.6%below the sector's middle half--38.6%below the sector's middle half▼ 30.0pp-72.0%below the sector's middle half▼ 33.4pp
Current ratio0.48below the sector's middle half-0.37below the sector's middle half▼ 0.110.28below the sector's middle half▼ 0.08
Return on assets (ROA)-16.0%below the sector's middle half--29.8%below the sector's middle half▼ 13.8pp-24.9%below the sector's middle half▲ 4.9pp
Staff (FTE)1-1.5▲ 50.0%1.2▼ 20.0%
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result stays negative: a loss of €7,225 in 2025 against €10,843 in 2024; the loss shrinks.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €32,014
Fixed assets
€20,126 ▼ 16.6%
Current assets
€11,888 ▼ 20.5%
Key figures and ratios
EBITDA
-€3,225▲
2024 · -€6,843
Cash flow
-€3,966▲
2024 · -€7,634
Quick ratio
0.23▲
2024 · 0.13
Debt to equity
-2.39▲
2024 · -3.59
Interest coverage
-3.72▲
2024 · -8.02
Debt ≤ 1 year
€41,788▲
2024 · €40,773
Debt > 1 year
€13,074=
2024 · €13,074
Staff costs
€44,543▼
2024 · €51,945
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 7,657 companies that looked in July 2024 the way this one looks now, 8.2% went bankrupt within 24 months and 84% are still going.
- Micro
- 2 to 5 years old
- negative equity
- a loss of 10% of the balance sheet or more
8.2%
went bankrupt
5.3%
stopped otherwise
84%
still going
A further 2.0% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a lower bankruptcy probability: 0.4% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,662 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.4% |
| 3 | 0.5% | 0.5% |
| 4 | 0.6% | 0.7% |
| 5 | 0.8% | 0.9% |
| 6 | 1.2% | 1.3% |
| 7 | 1.5% | 1.7% |
| 8 | 1.7% | 1.7% |
| 9 | 2.7% | 2.8% |
| 10 | 5.3% | 5.7% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 75% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 7,657 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|
| Remuneration, social security and pensions62 | €12,406 | €51,945 | €44,543 | ▼ 14.2% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €1,074 | €4,000 | €4,000 | = |
| Other operating charges640/8 | €422 | €4,454 | €1,364 | ▼ 69.4% |
| Gross operating margin9900 | €7,881 | €49,556 | €42,681 | ▼ 13.9% |
| Operating profit (loss)9901 | -€6,021 | -€10,843 | -€7,225 | ▲ 33.4% |
| Financial income75/76B | - | €62 | €128 | ▲ 105% |
| Recurring financial income75 | - | €62 | €128 | ▲ 105% |
| Financial charges65/66B | €424 | €853 | €868 | ▲ 1.7% |
| Recurring financial charges65 | €424 | €853 | €868 | ▲ 1.7% |
| Profit (loss) for the period before taxes9903 | -€6,445 | -€11,634 | -€7,966 | ▲ 31.5% |
| Profit (loss) for the period9904 | -€6,445 | -€11,634 | -€7,966 | ▲ 31.5% |
| Profit (loss) for the period to be appropriated9905 | -€6,445 | -€11,634 | -€7,966 | ▲ 31.5% |
| Line | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|
| Assets | ||||
| Total assets20/58 | €40,274 | €39,082 | €32,014 | ▼ 18.1% |
| Fixed assets21/28 | €28,126 | €24,126 | €20,126 | ▼ 16.6% |
| Tangible fixed assets22/27 | €18,926 | €14,926 | €10,926 | ▼ 26.8% |
| Plant, machinery and equipment23 | €18,926 | €14,926 | €10,926 | ▼ 26.8% |
| Financial fixed assets28 | €9,200 | €9,200 | €9,200 | = |
| Current assets29/58 | €12,148 | €14,956 | €11,888 | ▼ 20.5% |
| Stocks and contracts in progress3 | - | €9,644 | €2,427 | ▼ 74.8% |
| Stocks30/36 | - | €9,644 | €2,427 | ▼ 74.8% |
| Amounts receivable within one year40/41 | €5,551 | €3,315 | €7,408 | ▲ 123% |
| Trade receivables40 | €5,551 | €3,315 | €7,408 | ▲ 123% |
| Cash at bank and in hand54/58 | €6,596 | €1,997 | €2,053 | ▲ 2.8% |
| Equity and liabilities | ||||
| Total equity and liabilities10/49 | €40,274 | €39,082 | €32,014 | ▼ 18.1% |
| Equity10/15 | -€3,445 | -€15,079 | -€23,045 | ▼ 52.8% |
| Contributions10/11 | €3,000 | €3,000 | €3,000 | = |
| Profit (loss) carried forward14 | -€6,445 | -€18,079 | -€26,045 | ▼ 44.1% |
| Amounts payable17/49 | €43,719 | €54,161 | €55,058 | ▲ 1.7% |
| Amounts payable after more than one year17 | €17,568 | €13,074 | €13,074 | = |
| Financial debts170/4 | €17,568 | €13,074 | €13,074 | = |
| Amounts payable within one year42/48 | €25,468 | €40,773 | €41,788 | ▲ 2.5% |
| Current portion of amounts payable after more than one year42 | €5,432 | €7,777 | €6,691 | ▼ 14.0% |
| Financial debts43 | €9,000 | €9,000 | €9,000 | = |
| Credit institutions430/8 | €9,000 | €9,000 | €9,000 | = |
| Trade debts44 | €1,129 | €9,060 | €8,411 | ▼ 7.2% |
| Suppliers440/4 | €1,129 | €9,060 | €8,411 | ▼ 7.2% |
| Advances received on contracts in progress46 | - | - | €3,606 | - |
| Taxes, remuneration and social security45 | €8,320 | €12,013 | €10,128 | ▼ 15.7% |
| Taxes450/3 | €3,554 | €4,893 | €5,120 | ▲ 4.7% |
| Remuneration and social security454/9 | €4,766 | €7,120 | €5,008 | ▼ 29.7% |
| Other amounts payable47/48 | €1,587 | €2,923 | €3,952 | ▲ 35.2% |
| Accrued charges and deferred income492/3 | €683 | €314 | €196 | ▼ 37.5% |
| Line | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|
| Profit (loss) for the period9904 | -€6,445 | -€11,634 | -€7,966 | ▲ 31.5% |
| + Depreciation and write-downs630 | €1,074 | €4,000 | €4,000 | = |
| Operating cash flow (approximation) | -€5,371 | -€7,634 | -€3,966 | ▲ 48.1% |
| Investment in fixed assets (approximation) | - | €0 | €0 | - |
| Change in cash | - | -€4,600 | €56 | ▲ 101% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
11-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
10-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Weakest financial yearnet -€11,634
Net result drops to -€11,634, the lowest in the series; recovery starts the following year.
09-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 1 act read
About the unread acts
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Leuven · 1 establishment unit since 2023
Ground area
5,123 m²
Building footprint
300 m²
Volume, LiDAR
2,741 m³
Parcel 24062A1021/00T003, Flanders · tallest building 16.5 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Body RevoLUTion
since 20232.349.029.006
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24062A1021/00T003 | Flanders | 5,123 m² | 1 · 300 m² | 16.5 m · 2 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Public money · subsidies and aid
Flemish government
2024 · 1 entry · 750 EUR awarded · 750 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2024 | 1 | 750 EUR | 750 EUR |
Similar companies · same sector and region
Artsenpraktijk Grauls-Goeminne BV BVBA & Kornati BV BVBA FV
BE 0525.741.780
Leuven
Belgian Association for Complementary and Alternative Medicine
BE 0502.962.618
Leuven
Dokter Sara Ulens
BE 0841.219.533
Leuven
FRESA
BE 0873.162.524
Leuven
Hippo and Friends
BE 0728.817.319
Leuven
This company's figures show no positive equity and no headcount, so a size comparison is not possible. These companies share only the sector and the region. Of 10,437 companies in sector 86995 we hold annual accounts for 886. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded06-09-2023
Fiscal year end31-12
Activities, NACEBEL 2025
86995Nutrition and dietetics services
93130Fitness centres
E-invoicing
Reachable via Peppol
Peppol ID
0208:0805550752
Also
9925:BE0805550752
Registered
20-11-2025
Register as of 28 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.